Market Quick Take - September 9, 2020 Market Quick Take - September 9, 2020 Market Quick Take - September 9, 2020

Market Quick Take - September 9, 2020

John Hardy

Head of FX Strategy

Summary:  US stocks continued their steep descent yesterday, with the Nasdaq 100 suffering nearly a five percent drop. The broader market fared rather better, but still suffered an ugly day, while European equities have managed so far to trade within the tight range of the last two months. Elsewhere, oil prices went into a nosedive and the USD and JPY have risen sharply on save haven demand.

What is our trading focus?

  • S&P 500 Index (US500.I) and NASDAQ 100 Index (USNAS100.I) – yesterday was another tough session for the bulls as Nasdaq 100 and S&P 500 were down 4% and 2.4% respectively. The declines continued into today’s session, but technical buying has pushed up both index futures with Nasdaq 100 futures up 1%. From the all-time high last week to the local lows today the drawdown in Nasdaq 100 is 12.3% which is in line with a normal correction in a high volatility asset. Before everyone goes out at sell every technology stock they own, let us make two key observations. Nasdaq 100 is valued at a free cash flow yield of 3.3%, which is quite attractive vs bonds given the underlying growth, and the digitalization of the economy will continue for another decade.

  • STOXX 50 Index (EU50.I) – the index was firmly rejected around the 3,300 level yesterday and it is now back into the lower half of the 3,200-3,400 trading range that the market has been boxed into the last five weeks. There is simply a lack of positive narrative as the resurgence in COVID-19 cases is causing uncertainty over the economic rebound in Europe. We wrote a research note on European equities yesterday which shows how fragmented the European equity market is terms of performance. Our view is that investors should take an active and stock picking approach to European equities.

  • EURGBP and GBPUSD sterling suffered one of its weakest days in recent memory, dropping on the aggressive new stance taken by Boris Johnson in Brexit negotiations, as he seeks a deal by October 15 and has laid the groundwork to override some of the original conditions that led to the Brexit withdrawal agreement in the first place. GBPUSD traded all the way below 1.3000 and could tumble further to 1.2750 or lower, while EURGBP suddenly finds itself back above 0.9000 and within shouting distance of the range highs of the last few months into 0.9150-75.

  • Spot Gold (XAUUSD) - once again managed to bounce higher after finding support ahead of $1900/oz. US-China tensions and a drop in bond yields amid the continued stock market weakness offsetting the negative impact of a stronger dollar. The AstraZeneca vaccine news (see below) may potentially add another layer of support given the obstacles companies may have in finding a workable and safe vaccine. Additional weakness likely to be led by dollar strength (short covering) and gold becoming the ATM should the current stock market weakness accelerate further. Having been long since $1765/oz, our breakout model will go neutral on a break below $1902/oz.

  • WTI Crude Oil (OILUSOCT20) & Brent Crude Oil (OILUKNOV20) - Brent’s first sub-$40 close since Mid-June could signal a deeper short-term correction towards $37/b. Driven by doubts about the strength of the global demand recovery amid a pandemic not yet under control and concerns that a Covid-19 vaccine may get delayed. Adding to these a souring risk sentiment filtering through from stocks and the bullish narrative has suddenly been turned on its head with momentum and breakout strategies being forced to cut long positions. Later today at 16:00 GMT, the EIA will publish its Short-Term Energy Outlook followed by the API stock report at 20:30 GMT. EIA’s weekly stock report delayed until Thursday.

  • USDCAD – USDCAD has put in a solid bounce from the sub-1.3000 lows and is fast approaching a key resistance zone into 1.3300-50 ahead of today’s Bank of Canada meeting after the volatility in equity markets and especially the ugly slide in crude oil have weighed on CAD in recent days. At the prior Bank of Canada meeting, the BoC provided forward guidance in a commitment to keep rates at 0.25% for at least two more years and purchase CAD 5 billion per week of Canadian government bonds. No significant shifts in the BoC outlook are expected.

  • Tesla (TSLA:xnas) - shares were down 18% ending the session at the lows taking the drawdown from last week to 34.4% wiping out gains across cash stocks and weekly call options. The stock is still up 292% for the year meaning that many likely sits on gains that they now want to lock in thus putting massive selling pressure on the stock. Also, short sellers might be smelling blood re-entering their positions adding further pressure. The levels 300 and 273 are the next critical support levels for the stock.

  • Zscaler (ZS:xnas) – reports FY20 Q4 earnings (ending 31 July) tonight after the US market close. Zscaler is software security company offering various online security solutions and has been growing rapidly at +35% growth rate for the past 10 quarters. Even in the quarter ending 30 April the company managed to increase its growth rate highlighting its robustness amid the COVID-19 pandemic.

What is going on?

  • Phase 3 trials of AstraZeneca COVID-19 vaccine candidate halted after a participant in the trial caught an unexplained illness. This vaccine candidate, developed in cooperation with Oxford University, is one of the most advanced in terms of the testing process.  The pause in the trial is a precautionary step and it is unknown whether the illness is linked to the vaccine. AstraZeneca shares (AZN:xlon) will bear watching in today’s UK session.

  • UK is limiting public gatherings to six people as the UK is suffering a resurgence of COVID-19 cases.

  • Berkshire Hathaway to invest $570mn in Snowflake IPO in an unusual step for the investment company that has rarely participated in IPOs. Berkshire Hathaway has almost entirely missed the digitialization except for its investment in Apple, and its previous investment in IBM was an utter failure, so in that sense the investment in Snowflake makes sense and also because cloud infrastructure has interesting business characteristics. The decision is interesting given the latest talks about a style drift at SoftBank Group.

What we are watching next?

  • The degree to which market volatility is a US-only phenomenon. So far we have seen very little contagion from the US market volatility to the rest of the world, just as the last legs of the huge rally in US megacaps before this recent sell-off was also a US-only development. If this episode continues to fail to spread wider contagion, global markets can avoid wider fall-out.

  • Boris Johnson’s aggressive Brexit stance making waves, with sterling selling off steeply as the market begins to price in the risk that the UK is willing to end the Brexit transition period with No Deal rather than submit to EU terms on fisheries and especially state aid (UK internal investments favouring various industries). The pressure on the pound could build further if talks this week fail to budge the EU’s position. Boris Johnson has set an October 15 deadline for striking an agreement.

  • ECB Meeting tomorrow – to what degree does the ECB believe it can engineer a higher level of inflation and what will have on offer at this Thursday’s meeting? The market is beginning to price in higher likelihood of another rate cut and an expansion of the PEPP programme of QE is likely in the works at this meeting, but can these measures and other guidance move the needle?

  • WASDE on Friday will be watched closely by the grain market following recent strong gains and rapid rise in speculative longs. The rally during the past few months has been driven by dry US weather potentially hurting crop prospects and strong Chinese demand. The combined speculative long in corn, wheat and soybeans sits at 325,000 lots or 1.6 billion bushels above the five-year average. This at a time of year where funds generally tend to be net sellers given the lack of unknowns ahead of the arrival of the new harvest.

Economic Calendar Highlights for today (times GMT)

  • 1215 – Canada Aug. Housing Starts
  • 1400 – Canada Bank of Canada Rate Decision
  • 1400 – US Jul. JOLTS Job Openings
  • 1600 – EIA's Short-Term Energy Outlook
  • 1700 – US 10-year Treasury Note Auction
  • 2230 – American Petroleum Institute weekly stock report
  • 2301 – UK Aug. RICS House Price Balance

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Latest Market Insights

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 07

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
  • The rise of populism: Far-right parties will influence the future

    The disheartening cycle of unresolved geopolitical conflicts, the rise of polarizing political parties, and the stagnation of productivity.

    Read article
  • Investing in China: Navigating Q1 amid economic challenges

    Understand China's political landscape in Q4 2023 and the impact on counter-cyclical initiatives, with a focus on the pivotal Q1 2024.

    Read article

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.